ConductScience.org, home

Trial · NCT07913789

Opioid Free Anesthesia Combined With Pectoral Nerve Block (PECS Block) in Breast Cancer Surgery

NCT07913789, Not applicable, Completed, Tanta University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Opioid Free Anesthesia Combined With Pectoral Nerve Block (PECS Block) in Breast Cancer Surgery. Trials, record NCT07913789. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913789

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Opioid Free Anesthesia Combined With Pectoral Nerve Block (PECS Block) in Breast Cancer Surgery
NCT number
NCT07913789
Status
Completed
Phases
Not applicable
Enrollment
60 participants, actual
Lead sponsor
Tanta University
Conditions
Opioid Free Anesthesia, Pectoral Nerve Block, Breast Cancer Surgery
Interventions
Opioid Free Anesthesia, Opioid based anesthesia
First posted
2026-11-03
Last updated
2026-11-03

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTotal morphine consumption24 hours postoperativelyFor each patient with \[Visual Analogue Scale (VAS) \> 4\], 3 mg of morphine will be prescribed as rescue analgesia to be repeated after 30 min if pain persists until the VAS\< 4.
SecondaryHeart rateTill the end of surgery (Up to 2 hours)Heart rate was recorded at baseline, after performing of block, and every 15 min till the end of surgery.
SecondaryMean arterial blood pressureTill the end of surgery (Up to 2 hours)Mean arterial blood pressure was recorded at baseline, after performing of block, and every 15 min till the end of surgery.
SecondaryDegree of pain24 hours postoperativelyAll the participants were explained about postoperative pain assessment with the visual analogue scale (VAS), from 0 to 10 (0 represents "no pain" while 10 represents "the worst pain imaginable")
SecondaryTime to extubationTill the extubating (Up to 60 minutes)The time to extubate was counted starting from stoppage of inhalational anesthetic agent till the extubating was practiced.
SecondaryQuality of recovery24 hours postoperativelyQuality of recovery was assessed using Modified Aldrete Score (depending on conscious level, activity of the patient, breathing, blood pressure, oxygen saturation).
SecondaryTime to the 1st rescue analgesia24 hours postoperativelyTime to the first request for the rescue analgesia was recorded from end of surgery to first dose of morphine administrated.
SecondaryIncidence of side effects24 hours postoperativelyIncidence of side effects such as bradycardia, hypotension, nausea, vomiting, respiratory depression, hematoma at the site of injection, and local anesthetic toxicity were recorded.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07913789

GET https://conductscience.org/api/trials/v1/NCT07913789/registered